INVESTOR NOTICE: Corcept Therapeutics (CORT) Investors with Substantial Losses Have Opportunity to Lead the Investor Class Action - Hagens Berman

SAN FRANCISCO, April 15, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) of the critical April 21, 2026 lead plaintiff deadline in the pending securities class action. The firm urges investors...